HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

XLR-11

synthetic cannabinoid; structure in first source
Also Known As:
(1-(5-fluoropentyl)indol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone; XLR11
Networked: 7 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Al-Eitan, Laith: 1 article (12/2020)
2. Alahmad, Saif: 1 article (12/2020)
3. Alhusban, Ahmed: 1 article (12/2020)
4. Bauman, Michael H: 1 article (01/2020)
5. Bi, Guo-Hua: 1 article (01/2020)
6. Galaj, Ewa: 1 article (01/2020)
7. Gardner, Eliot L: 1 article (01/2020)
8. He, Yi: 1 article (01/2020)
9. Wang, Xiao-Fei: 1 article (01/2020)
10. Xi, Zheng-Xiong: 1 article (01/2020)

Related Diseases

1. Brain Injuries (Brain Injury)
2. Catalepsy
3. Acute Kidney Injury (Acute Renal Failure)
4. Stroke (Strokes)
5. Necrosis

Related Drugs and Biologics

1. Cannabinoid Receptor Agonists
2. CB2 Cannabinoid Receptor
3. Dronabinol (THC)
4. Rimonabant
5. (1- pentyl- 1H- indol- 3- yl)(2,2,3,3- tetramethylcyclopropyl)methanone
6. (3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)

Related Therapies and Procedures

1. Analgesia